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Abstract

A key factor in the development of type II diabetes is the loss of insulin-producing
pancreatic beta cells. The amyloidogenic human Islet Amyloid Polypeptide (hIAPP, also known
as human amylin) is believed to play a crucial role in this biological process. Previous studies
have shown that hIAPP forms small aggregates that kill β-cells by disrupting the cellular
membrane. In this study we report membrane fragmentation by hIAPP20-29 and the rat version,
rIAPP20-29, using solid-state NMR experiments on nanotube arrays of anodic aluminum oxide
containing aligned phospholipid membranes.
31

P NMR results suggest that membrane fragmentation by hIAPP is related to peptide

aggregation as the presence of Congo red, an inhibitor of amyloid formation, prevented
membrane fragmentation, and the non-amyloidogenic rat IAPP did not cause membrane
fragmentation. DSC studies suggest membrane disordering is caused by both fragments of
peptides, possibly due to extensive aggregation on the surface. 13C-1H NMR results suggest that
rIAPP20-29 causes transient deformations of the bilayer by intercalating into the hydrophobic core.
Last, dye leakage experiments indicate that both peptides induce membrane permeability,
although a greater effect is seen for the hIAPP.
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1. Introduction

1.1 Amino Acids, Proteins, and Peptides
Proteins are macromolecules present abundantly in all cells and all parts of cells.
They exhibit different sizes, ranging from small peptides to huge polymers with millions of
Daltons in molecular weight. All proteins are constructed from a set of 20 amino acids
covalently linked in a characteristic sequence. These amino acids are called the building
blocks of living organisms. Proteins are the dehydrated polymers of amino acids with each
amino acid residue joined to its neighbor by a covalent amide bond.
All amino acids have a carboxyl group and amino group bonded to the same carbon
atom (α carbon). These amino acids differ from each other in their side chains, or R groups,
which vary in structure, size, and charge, and this influences the solubility of the amino acids
in water.
Figure 1 shows the 20 common amino acids. Amino acids are classified based on the
polarity and charge (at pH 7) of their R groups. The nonpolar, aliphatic class includes
alanine, glycine, isolecuine, leucine, methionine, proline, and valine. Because of the aromatic
side chains in phenylalanine, tryptophan, and tyrosine, they are relatively hydrophobic. The
polar, uncharged class includes aspargine, cysteine, glutamine, serine, and threonine. The
negatively charged (acidic) amino acids are aspartate and glutamate. The positively charged
(basic) amino acids are arginine, histidine, and lysine.
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Figure 1: List of 20 amino acid structures in uncharged form.
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Peptides and proteins are the polymers of amino acids. A condensation reaction is a
common class of reaction in living cells responsible for the formation of peptides from amino
acids. Two amino acids can be covalently joined by amide linkage, termed as a peptide bond.
Such a peptide bond is formed by removal of water from alpha-carboxyl group of one amino
acid and the alpha-amino group of another. When a few amino acids are joined in this
fashion it is termed an oligopeptide, and when many amino acids are joined it is called a
polypeptide. Proteins are very long polypeptide chains of 100 to several thousand amino
acid residues. The amino acid sequence provides important biochemical information. Certain
amino acid sequences often serve as signals that determine the cellular location. The
difference in protein function is the result of differences in the amino acid composition and
sequence.1
1.2 Amyloid Formation by Polypeptides and Proteins
1.2.1 Amyloid
Rudolph Virchow first introduced and popularized the term amyloid in 1854 to denote
a macroscopic tissue abnormality in brain that exhibited a positive iodine staining reaction.
Virchow concluded the substance was a type of cellulose and named it amyloid. Later,
Friedrich and Kekule demonstrated the presence of protein in an amyloid mass and the
apparent absence of carbohydrate.2 Today amyloid refers to the fibrillar structure resulting
from aggregation and self-assembly of proteins, peptides and polypeptides. Amyloid
formation is the major component of degenerative processes in a number of diseases such as
Alzhemimer’s and Parkinson’s disease. In most of the diseases, amyloid is closely related to
the extent of disease progression, which suggests that amyloid formation may contribute to
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degenerative processes such as cell death. In each of these diseases, a characteristic protein
assembles into highly ordered beta sheet-rich amyloid fibers.3
1.2.2 Amyloid Fibril Formation and Mechanism of Toxicity
Amyloid fibril formation is a hallmark of a variety of human disorders.4 Extensive
experimental evidence suggests that amyloid formation by polypeptides proceeds through a
nucleation-dependent polymerization pathway.2, 5 The two phases observed in amyloid
formation are the lag phase and elongation phase. Protein misfolding leads to the formation
of oligomeric nuclei in the lag phase, leading to seed formation. The resulting seeds are
responsible for a rapid elongation phase, which results in fibril formation.6
The nuclear dependent seeded growth is shown in Figure 2, where monomers are
responsible for formation of the nucleus in the lag phase and the resultant nucleus undergoes
aggregation as a result of seeded growth by monomers.

Figure 2: Schematic representation of nucleation dependent aggregation to form a fibril. The
nucleus is created by slow addition of monomers, and addition of these monomers to a
nucleus results in aggregation. Figure adapted from reference 7.
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Aggregating proteins such as amylin have been reported to exist in an -helix,
random coil, and beta sheet in solution.8 An alternative for the cross beta structure is the beta
helical structure, which has been suggested as a generic structure for the amyloid fibril. In the
beta helical models, one or more beta sheets wrap around the hollow core in a helical
manner.9
In the process of amyloid fibrillization, there is an intermediate formation of nonfibrillar soluble stages called oligomers. These appear early in the fibrillization pathway and
are found to be the cytotoxic form of amyloid complexes.10, 11 The mature amyloid fibrils
are thought to replace β-cell mass and are less cytotoxic than the soluble oligomers. A more
thorough knowledge of the mechanism of amyloid formation and amyloid toxicity is
necessary to understand the progression of the amyloid disease.
1.3 Islet Amyoid Polypeptide (IAPP, Amylin)
Amylin is also known as islet amyloid polypeptide (IAPP). Amylin is a 37 amino acid
residue protein produced in the islet of β-cells in the pancreas and co-secreted along with
insulin. Amylin belongs to the family Calcitnonin Peptides. It is one of peptides with the
ability to form amyloid deposits and cause cell death. The pathological feature of type II
diabetes (T2DM) is deposit of amylin (islet amyloid polypeptide) in pancreatic islets.2, 12 The
regulation of IAPP in the beta cell is influenced in a number of ways and studies suggest that
IAPP and insulin may be released from the beta cells of the pancreas in different ratios.
These two hormones play an important role in the regulation of glucose levels. Insulin causes
an uptake of glucose into cells, lowering blood glucose levels. Amylin slows the rate of
glucose entry into the bloodstream. They therefore work together to keep blood glucose
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levels in check. IAPP also has been found to influence different physiological processes like
bone formation.13
1.4 The Role of Insulin and IAPP in Type II Diabetes
Insulin is released by the pancreas to normalize the blood glucose level and acts as a
key for the cells to utilize the glucose. Small groups of beta cells called islets of langerhans
are present in the pancreas and are responsible for the production of the hormone insulin.
This released insulin travels to all the parts of the body. Most of the actions of insulin are
involved in the control of metabolism of carbohydrates and proteins. Insulin is also important
in regulating the cells of the body, including their growth. A condition where cells of the
body become resistant to the effects of insulin is called insulin resistance. As a result, high
levels of insulin are needed to have an effect. The absolute lack of insulin is the main
disorder in type I diabetes. In type II diabetes there is a steady decline of beta cells that
results in elevated blood sugar levels. Insulin resistance precedes the development of
diabetes type II. Usually type II diabetes occurs in later life. Type II diabetes is also referred
to as non-insulin dependent diabetes mellitus (NIDDM) or adult onset diabetes mellitus
(AODM) and is the most common type of diabetes. The disease is increasing with the
expanding percentage of elderly within our population. The progression of the disease is
roughly divided into two phases. In first phase of the disease, the body develops resistance to
insulin. In the second phase, there is a steady decline in the beta cell production of insulin,
and this contributes to decreasing glucose control. The combination of both decreased insulin
sensitivity and decreased insulin production leads to the development of type II diabetes. The
loss of insulin-producing pancreatic beta cells is linked to the toxicity of human Islet
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Amyloid Polypeptide (hIAPP).14 IAPP has been found to be the prime component in the
immunohistochemical investigation of amyloid deposits, along with several other proteins.5
1.5. Fibril Formation by IAPP and Structural Studies
Amyloid fibrils formed by IAPP are highly ordered proteins and are associated with
several human disorders. The soluble precursors of the amyloidogenic proteins do not share
any sequence homology. Increasing evidence suggests the importance of IAPP misfolding in
type 2 diabetes.15 Evidence suggests that IAPP is amyloidogenic in humans, monkeys, and
cats, and these species are known to develop T2DM. In contrast, rats and mice do not
develop T2DM, and the IAPP’s are non-amyloidogenic and appear to be non toxic.16
The human IAPP sequence is amyloidogenic. The rat sequence shares a similarity
with the human sequence but has the nonconserved amino acids. A comparison of IAPP
sequences between mammals such as humans that develop type II diabetes and mammals
such as rats that do not develop type II diabetes revealed differences in a ten amino acid
stretch in the segment 20-29 (SNNFGAILSS in the human sequence, SNNLGPVLPP in the
rat sequence) shown in Table 1. Studies have shown that the 20-29 fragment of hIAPP
(hIAPP20-29) is amyloidogenic whereas the 20-29 fragment of rat (rIAPP20-29) is nonamyloidogneic.
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Table 1: Comparison of human and rat IAPP sequences.
Animal Species

1-37 Sequence
1

10

11

19 20

29 30

37

Human

KCNTATCATQ

RLANFLVHS SNNFGAILSS TNVGSNTY

Rat

KCNTATCATQ

RLANFLVRS

SNNLGPVLPP TNVGSNTY

The proline substitutions in the rIAPP20-29 play an important role in preventing the
folding of the peptide into the beta conformation and assembly into amyloid fibrils. This
illustrates the critical role of the sequence for fibrillogenesis.17
A conserved disulfide bond is present between cysteines at positions 2 and 7 in
mature IAPP fibrils in all species. These seven N-terminal residues were found not to be the
amyloid fibril core, and it has been found that synthetic peptides lacking these seven residues
of IAPP form similar amyloid fibrils to those of hIAPP8-37, implying that cysteines are not
necessary for amyloid fibril formation.18, 19
The hIAPP20-29 analog is often used as a model system to study amyloid formation
and has been proposed to show a cross-linked beta structure. Detailed investigation of
residues 20-29 suggests that residues 22-27 (NFGAIL) make up the minimum amyloid
forming fragment.20, 21 Negative stain electron microscopy studies indicate that peptide
fragments corresponding to LANFLV (residues 12-17) and FLVHSS (residues 15-20) were
strong enhancers of beta sheet transition and fibril formation when incubated alone in
solution. Circular dichroism analysis revealed acceleration of fiber formation by full length
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human IAPP in the presence of LANFLV and FLVHSS, where the latter two fragments were
found to recruit additional IAPP molecules during fibril formation.12, 22
A study reported the transformation of an amyloidogenic peptide sequence of amylin
(20-29) into its corresponding peptoid (N-substituted glycine) and retropeptoid sequences to
design a novel class of beta sheet breaker peptides as amyloid inhibitors. They found that the
peptide sequence did not form amyloid fibrils or any other secondary structures and was able
to inhibit amyloid formation of native amylin (20-29)23.
Circular dichroism and electron microscopy studies of hIAPP1-37, hIAPP8-37, and
hIAPP20-29 revealed that fibril formation was accompanied by a conformational change. The
hIAPP20-29 has been found to contribute to the fibril’s beta sheet core.19 Circular dichroism
and fluorescence spectroscopy investigation on IAPP have revealed that conditions that
promote weakly stable alpha helical conformations may promote IAPP aggregation.
Acceleration in IAPP aggregation has been observed in the presence of negatively charged
phosphatidylserine (PS).8

9

1.6 Models for Membrane Disruption
hIAPP permeabilizes membranes either through formation of specific channels
(pores) or through a less specific induction of curvature strain or a detergent-like
permeabilization of lipid membranes. Studies have shown that depending on conditions,
membrane-lytic host defense membranes permeabilize membranes in three ways. When
unstructured peptides in solution approach membrane (Fig. 3A) at low concentrations,
peptides are assumed to be monomeric (Fig. 3B) on the surface, but at higher concentrations
they may self-assemble (Fig. 3C). At even higher concentrations, the peptide disrupts
membranes usually in one of three ways (Fig 3D-F). The first one is known as the “barrelstave model” where peptides aggregate to form transmembrane pores (Fig. 3D). The second
one is “detergent-like” or “carpet model,” where surface-associated peptides form micellelike membrane-disruptive structures made of both peptides and lipids. No distinct pore is
seen, but a local disruption of the membrane is caused by the high density of the peptide (Fig.
3F). The third is a “toroidal wormhole” model where both the peptides and lipids line inside
a pore, destabilizing the membrane and leading to formation of a toroidal lipid-peptide pore
(Fig. 3E).24, 25
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Figure 3: Overview of interactions between peptides and lipids showing the different possible
mechanisms. (A) Unstructured peptides in solution upon approaching the membrane. (B)
Peptide bound to the bilayer as monomer with a well-defined structure. (C) Self-assembled
peptides on the membrane surface. (D) “Barrel-Stave” structure of peptide forming a pore
across the membrane. (E) A “Torroidal wormhole” with a pore lining containing negatively
charged lipid head groups that compensate for the positive charge on the peptides. (F)
“Carpet Model” or “Detergent like model” structure shown where a high concentration of
peptides in a non-structured manner disrupts the membranes. Figure adapted from reference
26.
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In a number of studies, formation of a transmembrane pore, or hIAPP channel, has
been observed. Lansbury and colleagues also observed that hIAPP permeabilized lipids by a
pore-like mechanism where the pores were able to percolate calcium but not larger
molecules. Since the membrane permeability increased during the initial stages of
fibrilization and disappeared when the mature fibrils began to form, the authors concluded
that the pore formation is caused by an oligomeric, non-fibrillar form.27 Consistent with this
pore hypothesis, neutron diffraction has shown that hIAPP adopts a trans-bilayer orientation,
at least in the preparations made by dissolving the peptide with lipid.28
Some researchers observed that IAPP induced the formation of small defects on the
lipid surface. The defects were found to be small, stable, and able to spread over the entire
lipid surface. The membrane disruption of hIAPP could be due to the loss of lipid from the
membrane in a manner similar to the membrane disruption by surfactants such as Triton X100.29 In agreement with this data, Sparr et al. found that hIAPP aggregation involves
extraction of lipids from the bilayer, leading to disruption of bilayer barrier function and
membrane leakage.30
It was recently shown that soluble hIAPP monomers bind to the membranes and
cause membrane permeabilization. For both hIAPP and rIAPP, leakage of vesicles was
observed to occur during the lag phase of IAPP fiber formation. At this stage these were still
found to be largely in -helical conformation.31 Using atomic force microscopy, it was
detected that both rat and human IAPP can cause membrane fragmentation, although much
more rIAPP was needed to cause the membrane damage.29
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1.7 Overview of Solid Phase Peptide Synthesis
Solid-phase peptide synthesis (SPPS) was pioneered by Bruce Merrifield. It is now
the accepted method for creating peptides and proteins in the lab in a synthetic manner. SPPS
allows the synthesis of natural peptides; which are difficult to express in bacteria; the
incorporation of unnatural amino acids; peptide/protein backbone modification; and synthesis
of D-proteins, which consist solely of D-amino acids.
The general principle for SPPS is one of repeated cycles of coupling and
deprotection. The free N-terminal amine of a peptide attached to a solid-phase is coupled to a
single N-protected amino acid unit. The unit is then deprotected, revealing a new N-terminal
amine to which a further amino acid may be attached.
The overwhelmingly important consideration is to generate extremely high yield in
each step. There are two commonly used forms of protecting groups –Fmoc and Boc. The
N-terminii of amino acid monomers are protected by one of these two groups and added onto
a deprotected amino acid chain. Fmoc stands for the (F)luorenyl-(m)eth(o)xy-(c)arbonyl
protecting group. To remove an Fmoc from a growing peptide chain, basic conditions,
usually 20% piperidine in DMF, are used. Removal of side-chain protecting groups and
cleavage of the peptides from the resin are achieved by incubating in trifluoroacetic acid
(TFA). Fmoc deprotection is usually slow because the anionic nitrogen produced at the end is
not a particularly favorable product. The whole process is thermodynamically driven by the
evolution of carbon dioxide. Since no hydrofluoric acid is needed (as is required for the
cleavage of butyloxycarbonyl, Boc, protected peptides), it is therefore used for most routine
syntheses.
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1.8 Solid-State NMR Methods for Membrane Studies
NMR is a versatile tool for studying interactions between membrane-active peptides
and lipid membranes. There are many methods for studying intermolecular interactions with
solid-state NMR. It would be interesting to study the peptides in native biological membranes
where they are active. But real biological membranes are complicated systems containing
large numbers of different lipids and protein components. So it is hard to extract biophysical
information about specific lipid-peptide interactions. Since NMR is an insensitive method,
high concentrations of peptide are needed for the experiments, which are difficult to reach in
the native membrane environment. Much simplified model systems are used and usually
consist of one kind of peptide and one or two types of lipid. To obtain reproducible results,
synthetic lipids or extracts from a well-defined source are used.26
Under ambient conditions lipids exist in a gel phase, while native membranes exist
usually in a fluid state. Synthetic model membranes have a well-defined phase transition
temperature (Tm), which is determined by acyl chain length. Bilayers of DMPC (1,2dimyristoyl-sn-glycero-3-phosphocholine) were used as model membranes to investigate the
membrane interaction of hIAPP20-29 and rIAPP20-29. Natural membranes usually contain a
mixture of lipids with different head groups, and acyl chains with different lengths and
degrees of saturation. The lipid head group composition shows considerable variation
between different tissues, organisms, and organelles. However, recent studies have shown
that solid-state NMR spectroscopy of phospholipid bilayers is well suited for measurements
of structure, dynamics, and folding.32
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1.8.1 Sample Preparation for NMR studies
Aligned samples that display a high degree of order with respect to the external
magnetic field offer considerable advantages in determining the orientation of the peptide
with respect to the membrane. The existing mechanical or magnetic alignment of samples
may be difficult to determine for hIAPP since it shows a rapid membrane-catalyzed
aggregation. Magnetically aligned bicelles can only be oriented over a limited range of
temperatures and lipid compositions, thus eliminating the use of low temperatures as a
method of controlling hIAPP aggregation. Mechanically aligned glass plate samples can be
used for solid-state NMR experiments at low temperatures, and they must be hydrated at or
above room temperature. But at this point, the hIAPP peptide may aggregate during the
hydration period and may not be suitable for structural studies. Moreover, the peptide is
incorporated into the membrane directly through evaporation of a mixture of the lipid and
peptide before hydration. hIAPP is secreted as a soluble peptide and must bind to the
membrane from the cytosol. Bokvist et al. have observed that direct incorporation of the
peptide into the membrane may introduce artifacts in peptide conformation in the structural
determination of the peptide.33
Recently, Lorigan and co-workers have proposed the use of phospholipid bilayers
supported on anodized aluminum oxide nanotube arrays as a method of aligning samples for
solid-state NMR studies.34 Anodized aluminum oxide nanotube arrays (shown in Figure 4 )
offer many advantages for sample alignment for solid-state NMR.
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Figure 4. The anodized aluminum oxide nanotube array. The substrate array is shown
on the left. The pore size is shown in blue, and on the right a blow-up of water filled
phospholipids bilayer nanotube arrays is shown. Figure adapted from reference 34.
The sample can be directly hydrated by flushing buffer through the array prior to the
addition of the peptide. This allows the hydration of the phospholipid bilayer to take place
prior to the addition of the peptide, reducing the time hIAPP may undergo aggregation.
Moreover, phospholipid bilayers supported on nanotube arrays remain aligned at
temperatures as low as 155 K.35 Thus very low temperatures can be used to decrease or
eliminate hIAPP aggregation and increase sensitivity. Samples aged in solution with the
peptide for various time periods and then frozen can be used to study the time dependent
changes in the conformation of the peptide along with the aggregation process. The samples
can be rapidly prepared and immediately flash-frozen afterward.
Solid-state NMR spectroscopy is a valuable method to study the structure of amyloid
fibrils because they are insoluble, which makes it difficult to use solution state NMR for
structure determination. Solid-state NMR is adept at detecting molecular reorientations
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because nuclear spin frequencies inherently depend on the angle of molecule-fixed spin
interaction tensors with respect to the magnetic field.36
1.8.2

31

P NMR Spectroscopy of Membranes

Cell membranes consist of a very high proportion of phospholipids carrying a
phosphate moiety in their polar head group. So 31P is the most commonly used NMR active
nucleus in studies of membranes. 31P is a spin ½ nucleus with 100% natural abundance. Its
gyromagnetic ratio is 10840, approximately 40% of that for proton. It is a sensitive NMR
probe that is naturally abundant in membranes. The isotropic chemical shift in particular is
sensitive to changes in the electrostatic environment around the phosphorus nucleus.26, 36
31

P spectra are dominated by large chemical shift anisotropy (CSA) range and exhibit

a variety of line shapes for different types of lipid phases as shown in Figure 5. “Wide-line”
spectra for a lamellar bilayer, a hexagonal arrangement of lipid cylinders, and a spherical
micelle arrangement are shown in respectively in Figure 5 A, B, and C.26
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Figure 5: 31P NMR line shapes of different lipid morphologies. (A) Lamellar bilayer,
(B) inverted hexagonal phase, and (C) spherical micelle. Figure adapted from Ref 26.
Several isotropic phases like micelles, inverted micelles, various types of cubic
phases, and very small unilamellar vesicles will give rise to one sharp peak. 31P NMR is a
highly useful tool to study the induction of non-lamellar phases when peptides are added
because the presence of such phases indicates that the membrane is being disrupted. The
lateral domain formation can be detected by changes in the chemical shift anisotropy (CSA)
width, which reflects a structural response of the lipid head groups. The most common
reference scale used is 85% phosphoric acid set to 0 ppm.26 Line broadening due to chemical
shift anisotropy can be eliminated and resolution is improved by spinning the sample at its
magic angle (MAS). The observations of perturbations in the isotropic chemical shift using
MAS allow the identification of the individual lipids to which IAPP binds in a membrane of
mixed composition. MAS experiments can resolve slight differences in the isotropic
chemical shift of different lipid head groups; which is useful in studies of lipid mixtures.
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1.8.3 Proton Detected Local Field (PDLF) Spectroscopy
Magnetically aligned bicelles are increasingly used as model membrane in both
solution and solid-state NMR studies of structure, dynamics, and membrane interaction of
membrane-associated proteins. The two key parameters used in subsequent structural
analysis are dipolar coupling and chemical shift. PISEMA (Polarization Inversion and Spin
Exchange at Magic Angle) pulse is generally used to measure the dipolar and chemical shift.
The most popular approach to measure the heteronuclear dipolar couplings is to
determine the 2D separation of heteronuclear dipolar interactions according to the chemical
shifts. The dipolar couplings in a molecule correspond to the local magnetic fields. This class
of experiments is referred to as separated local field (SLF) spectroscopy. Depending on the
experimental design, the dipolar couplings between directly bonded 1H-13C spin pairs, as well
as weaker dipolar interactions between remote spins, can be assessed. The large 13C chemical
shift dispersion provides a high chemical resolution that aids in easy separation of dipolar
coupling multiplets. In all of the different experimental designs, a 13C signal is observed
during the detection period t2 as it evolves under the 13C chemical shift interaction and in the
presence of 1H decoupling.
In a research study, Dvinskikh et al. reported that 2D proton-detected local field
(PDLF), which is a laboratory-frame separated-local-field experiment, is suitable for the
measurement of long-range heteronuclear dipolar couplings. They compared three different
2D approaches for the measurement of 13C-1H dipolar interactions from the lipid molecules
in aligned bicelles containing 1,2-Dimyristoyl-sn-Glycero-3-phosphocholine (DMPC) and
dihexanoylphosphatidylcholine (DHPC) molecules under static conditions. Their results
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suggest that PISEMA and other rotating frame pulse sequences are not suitable for the
measurement of long-range heteronuclear dipolar couplings as they provide inaccurate values
when multiple protons are coupled to a 13C nucleus. They also demonstrated that with simple
modification in the 2D PDLF sequence, in addition to 1H-13C couplings, remote 13C-31P and
1

H-31P couplings from phospholipids can be measured in bicelles. They also showed that

structural information obtained from 13C spectra is not limited to the orientation of a single
bond C-H vector. Couplings between remote 13C and 1H spin and between 13C and 31P nuclei
are also accessible.37 In previous studies, Schmidt et al. have also been successful in using a
2D PDLF sequence to obtain high resolution SLF spectra of solids by overcoming the
difficulties found when multiple protons are coupled with a 13C nucleus.38
PDLF differs from the traditional method for measuring heteronuclear dipolar
couplings (Separated Local Field [SLF] experiments) because, in the conventional SLF
sequence, the 13C transverse magnetization evolves under multiple 1H-13C heteronuclear
dipolar couplings during the evolution period t1 (Figure 6a). In the proton-detected local field
(PDLF) experiment, the 1H transverse magnetization evolves under the local field of 13C
spins during t1 and is subsequently transferred to carbons for detection (Figure 6b). The
PDLF spectrum is then a simple superposition of individual dipolar couplings.
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Figure 6. Experimental protocols of 2D experiments used for the measurements of
heteronuclear dipolar couplings and the corresponding simulated dipolar coupling spectra. (a)
SLF, where 13C dipolar evolution occurs in the presence of abundant 1H spins. The resulting
spectrum has a complex multiplet-like structure reflecting the interaction of multiple protons
(b) PDLF, 1H dipolar evolution occurs in the presence of the rare 13C spin. At natural
abundance the 1H spin interacts with only a single 13C spin on average. Figure adapted from
reference 37.
1.9 Differential Scanning Calorimetry (DSC)
DSC is a thermo-analytical technique in which the difference in the amount of heat
required to increase the temperature of a sample and reference are measured as a function of
the temperature. Both the sample and reference are maintained at nearly the same
temperature throughout the experiment. The basic principle underlying this technique is that
when the sample undergoes a physical transformation more or less heat will need to flow to it
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than the reference to maintain both at the same temperature. This depends on whether the
process is exothermic or endothermic.
DSC experiments measure molar heat capacity required for phase transitions. If the
membrane is already disordered, due to the interfering effects of a peptide like IAPP, then the
heat required for the transition is reduced relative to the non-treated sample. These
measurements can be made on samples with vesicles and peptides and vesicles alone to
assess membrane activity.

22

2. Research Goals and Objectives
It has been known for many years that insoluble, highly aggregated amyloid deposits
of human IAPP are found post-mortem in the islets of Langerhans of pancreatic beta cells in
the majority of type II diabetic patients but not in non-diabetic patients. Because of the high
tissue visibility of amyloid deposits in diabetic patients, it has been assumed that fibrilization
of hIAPP plays an important role in the pathogenic development of the disease. The putative
link between hIAPP fibril formation and beta cell death has led to an interest in the
mechanism of fibril formation and structures of fibrils formed by hIAPP.21, 39 The mature
fibrils formed from IAPP in solution exert only a minimal cytotoxic effect on pancreatic beta
cells, a finding also reflected in studies of other diseases associated with amyloidogenic
peptides such as Aβ peptides that are related to Alzheimer’s disease.27, 30
Recently a substantial body of evidence suggests that the mature fibers are not the
cytotoxic species of hIAPP. Small, soluble oligomeric species of hIAPP have been
implicated in disrupting cellular homeostasis by binding to and disrupting the cellular
membrane.27 Comparatively little is known about the mechanism by which these oligomeric
species form or the method by which they cause pancreatic beta-cell death. Structural
information on hIAPP could be particularly important for understanding the process, as
peptides with similar sequences to hIAPP (such as the rat variant) fail to aggregate while
other peptides with dissimilar sequences and solution structures compared to hIAPP share
many properties in common with it in a membrane environment. High-resolution structures
of hIAPP in a membrane environment will provide insights into these differences and
commonalities and may facilitate the design of inhibitors that block the pathological action of
hIAPP.
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In this research we have synthesized both the 20-29 fragments of hIAPP and rIAPP
and used a highly sensitive fluorescence dye leakage method to detect the activity of the
peptides and the influence of membrane composition and solution effects on the aggregation
rate. We have also used a combination of solid-state NMR spectroscopy and differential
scanning calorimetric techniques to characterize the interaction of hIAPP with phospholipid
membranes and determined the structural factors affecting its aggregation and membrane
permeabilization.
2.1 Significance of Proposed Study
The measurement of changes in membrane structure in atomistic detail upon hIAPP
binding using solid-state NMR spectroscopy have enabled us to determine the mechanism of
membrane disruption by hIAPP. Changes in the membrane structure were directly monitored
by solid-state NMR techniques. For example, the fragmentation of the membrane into small
micellar structures was accompanied by the appearance of an isotropic peak in the 31P
spectrum while the formation of pores by transmembrane helices was determined using
chemical shift and dipolar coupling parameters. Such techniques have been used successfully
by the Ramamoorthy group to determine the mechanism of action of membrane-disruption
by antimicrobial peptides.40-43
A comparison of the structures of amyloidogenic human IAPP and the nonamyloidogenic analogue (rIAPP) will assist in the rational design of therapeutic compounds.
The rat IAPP shares 80% sequence homology with human IAPP and possesses a similar
global confirmation as determined by circular dichroism (CD) experiments, yet shows no
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amyloidogenic tendencies even though it inserts into the membranes as IAPP does ( although
with a lower affinity).44
The main strengths of the approach of this research were that hIAPP was studied in
biologically relevant, fully hydrated, membrane environments. Samples that mimic the lipid
components of beta-cell membranes were prepared for solid-state NMR experiments. The
IAPP peptide was added as an aqueous solution to the vesicles; organic solvents (which can
induce unnatural secondary structure formation) and dried samples (which can drastically
alter the conformation of the peptide) were avoided.
Moreover, the use of solid-state NMR spectroscopy has a clear advantage for the
study of hIAPP at atomic resolution over other structural techniques. For example, solution
NMR generally requires rapidly tumbling membrane mimetics such as detergent micelles.
This is a disadvantage in this system because of the divergence of the detergent micelle from
a membrane layer in terms of the acyl chain length, head group structure, and membrane
curvature. X-ray diffraction has proven to be fruitful in the study of amyloid fibers, but
getting hIAPP crystals in a membrane environment is difficult. Other techniques such as
FTIR and circular dichroism (CD) spectroscopy offer only global information about the
peptide and lack atomic level resolution and structural details.
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3. Experimental Procedures
3.1 Synthesis of human IAPP20-29 and rat IAPP20-29
The hIAPP20-29 and rIAPP20-29 peptides were synthesized by standard fmoc methods
with an amidated C-terminus and an acetylated N-terminus.
In this protocol both hIAPP20-29 and rIAPP20-29 were synthesized on a 0.4-mmol scale
using an automated peptide PS3 synthesizer. All the solvents used were ACS grade. Fmocprotected amino acids were purchased from Midwest Biotech, Inc., and Protein
Technologies, Inc. All other reagents were purchased from Fisher Scientific. The main
solvent was N,N-dimethylformamide (DMF) and 20% piperidine solution (v/v) in DMF was
used for deprotection. O-(Benzotriazol-1yl)-1,1,3,3-tetramethyluronium hexafluorophosphate
(HBTU) was used as a coupling agent, activated by 0.4 M N,N-diisopropylethylamine in
DMF. The synthesized 20-29 sequences are shown in Table 2.
Table 2. The 20-29 fragments of hIAPP and rIAPP.
Animal Species

20-29 sequence

Human

SNNFGAILSS

Rat

SNNLGPVLPP
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The required amino acids were weighed (0.4 mmol) and transferred into their
respective vials. HBTU (0.152 g) was added into each vial. The synthesis proceeded in a Cterminal to N-terminal fashion on MBHA (methyl benzhydryl amine) resin substituted at 0.6
mmol/g. The N terminus was then acetylated with 2 mL acetic anhydride.
3.2 Peptide Cleavage
After the completion of the synthesis, the resin was washed with DMF and the DMF
was drawn off by using a vacuum line. The peptide-resin was then rinsed with ethanol and
methylene chloride and dried under vacuum for about 1 hour. A cocktail was prepared in a
20 mL beaker in an ice bath by adding 0.5 mL of water and 0.5 mL of thioanisole along with
1 crystal of phenol and 10 mL of trifluoroacetic acid. This prepared cocktail was added to the
resin and stirred at room temperature for 2 ½ hours. This cleavage mixture was poured into a
coarse fritted glass funnel and the peptide solution was collected in a side-arm flask. The
beaker was rinsed with 3 mL of TFA, and 50 mL cold diethyl ether was added slowly with
swirling to precipitate out the peptide. The obtained precipitate was collected in a fine fritted
glass funnel. This peptide precipitate was allowed to dry under vacuum and was then
transferred into a small lyophilization flask. The peptide was then dissolved in a 70%
acetonitrile/water mixture, added to an equal volume of distilled water, and shell frozen by
rotating the flask in a dry ice/acetone bath. It was then lyophilized overnight.
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3.3 Peptide Purification and Analysis
The crude peptides were separated semipreparatively using reversed-phase highperformance liquid chromatography (RP-HPLC). A Waters HPLC with 501 and 510 model
pumps and a Waters 484 UV detector was used. A Phenomenex Jupiter column (C18, 10µm,
250 x 21.20 mm, 300Ǻ) was used to separate the peptide from impurities. A mobile phase
made of 0.1% TFA-water and 0.1% TFA-acetonitrile solutions was run with gradient
programming with a 10 mL/min flow rate and 10-50% organic component over 2 hours.
Based on the major peak absorbance, the pure peptide was collected in test tubes, frozen, and
lyophilized overnight.
Purity was determined by use of analytical RP-HPLC with a mobile phase made of
0.1% TFA-water and 0.1% TFA-acetonitrile solutions on a Phenomenex Jupiter column (5
µm, C18, 250 x 4.6 mm). The gradient used was 0-66% organic component over 33 minutes
with a flow rate of 1 mL/min. The purity was measured for both hIAPP20-29 and rIAPP20-29 as
greater than 95% by analytical HPLC with peak integration at 214 nm. The molecular weight
was verified by electrospray mass spectrometry (MS) as 1050 for hIAPP20-29 and 1048 for
rIAPP20-29.
3.4 Dye Leakage Assay
The ability of hIAPP20-29 and rIAPP20-29 to permeabilize a phospholipid bilayer was
studied using carboxyfluorescein dye entrapped LUVs (Large Unilamellar Vesicles). Vesicles
were treated with the fluorescent dye carboxyfluorescein followed by liquid nitrogen
freeze/thaw cycles and extrusion. The vesicles that took up the dye were purified through gel
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exclusion chromatography. Samples in sodium phosphate buffer were monitored for
increasing fluorescence over time using a fluorimeter. Upon membrane disruption by the
respective hIAPP20-29 and rIAPP20-29, the dye leaked out and the diluted dye fluoresced.
Fluorescence emission intensity at 520 nm was recorded as a function of time using the
excitation wavelength 490 nm. Total leakage was measured by addition of the detergent
Triton X. Percent leakage was then plotted versus time to monitor membrane disruption.
3.5 Preparation of Samples for NMR Measurements
Bilayers of DMPC were used as model membranes to investigate the membrane
interaction of hIAPP20-29 and rIAPP20-29. Aligned phospholipid bilayers were used to
determine the mechanism of membrane disruption by IAPP. Mechanically aligned bilayers
take several days for their preparation and the sample lacks bulk water. So in this study,
anodic aluminum oxide (AAO) nanotubes were chosen to rapidly align bilayers with excess
water. Previous studies have also demonstrated that the alignment of lipid bilayers in AAO
tubes is suitable for solid-state NMR experiments.34
To study membrane fragmentation, AAO discs containing 4 mg of DMPC and
between 0 and 4 mol percent of either hIAPP20-29 or rIAPP20-29 were examined in increments
of 0.25 mol % peptide by 31P NMR. The samples were prepared by deposition of
multilamellar vesicles (MLVs) onto AAO discs. MLV samples were prepared by mixing a
stock solution of the peptide in methanol (1 mg/mL) with 200 µL of a chloroform solution of
DMPC (20 mg/mL). The solvent was removed from the peptide/lipid samples by first drying
the sample under a stream of nitrogen and then by drying in a vacuum dessicator overnight to
completely remove any residual solvent. The resulting peptide/lipid film was directly
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hydrated with 70 µL of HEPES buffer (50 mM, pH 7.4) to form multilamellar vesicles. The
MLV sample was heated above the transition temperature of DMPC and then pipetted onto a
single 19 mm-radius AAO disc cut into 10 mm x 10 mm strips to fit into a 14х14х4 mm flatcoil probe. The sample was then sealed in a plastic bag along with some extra buffer (~200
µL) to prevent dehydration.
3.6
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P Solid-State NMR
A Chemagnetics/Varian 400 MHz mass spectrometer was used to obtain 31P chemical

shift spectra of DMPC bilayers containing varying concentrations of hIAPP20-29 and rIAPP2029.

A flat-coil (14×14×4 mm) probe was used with a spin echo sequence of (90°-τ -180°-τ, τ =

60 µs), with the bilayer normal perpendicular to the magnetic field at 37°C. 31P spectra were
referenced relative to liquid H3PO4. For each sample, 2048 transients were collected with a
recycle delay of 3 s and 60 Hz line broadening. The nanotube material itself has a broad
resonance (~20 ppm wide) centered ~10 ppm. This signal was subtracted for clarity.
3.7 Differential Scanning Calorimetry
Differential scanning calorimetry (DSC) experiments were performed using the
Nano-DSC II instrument (Calorimetry Sciences, Provo, UT, USA). The raw data were
converted to molar heat capacity using the CP Calc program provided with the calorimeter.
The molar heat capacities of the DMPC samples were measured in the presence of both the
hIAPP20-29 and rIAPP20-29. Experiments were performed on DMPC MLVs with rIAPP20-29
peptide/lipid mole ratios of 0.5%, 1%, and 4% and rIAPP20-29 peptide/lipid mole ratios of
0.5%, 0.75%, 1%, 2%, and 4%.
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4. Results and Discussion

4.1 Dye Leakage Analysis
The leakage of carboxyfluorescin dye as a function of time with various
concentrations of hIAPP20-29 was observed. Figure 7 shows the dye leakage profile upon
addition of hIAPP20-29. In this assay, membrane vesicles took up carboxyfluorescin dye and
were then treated with peptide. Membrane permeabilization induced by the peptide allowed
leakage of the dye from the vesicles, and the increase in fluorescence was monitored.
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a. Dye leakage in 10 minutes.
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Figure 7. Extent of carboxyfluorescein dye leakage as a function of time and varying
hIAPP20-29 concentrations. Dye leakage monitored in figure (a) was for 10 minutes and for 5
hours in Figure (b).
In Figure 7a, with the increase in peptide concentration from 12.5 µM to 25
µM and 50 µM, an increase in the percentage dye leakage was observed. The data clearly
indicates membrane disruption, although the percent leakage values are relatively low when
compared to that caused by antimicrobial peptides.45 In addition, the dual exponential at 50
µM for hIAPP20-29 suggests a multi-step process. The rIAPP20-29 analog gave similar results
(not shown), but the effect was weaker and fluorescence leveled off quickly, suggesting that
it is less membrane active than the human form, much like the full length peptides. In Figure
7 b, the lag phase may indicate the formation of oligomers or fibers.
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4.2 31P NMR Spectroscopy
The representative 31P chemical shift of DMPC bilayers containing various
concentrations of hIAPP20-29 and rIAPP20-29 are shown in Figure 8.

Figure 8.
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P chemical shift spectra of aligned DMPC bilayers containing various

mol% of IAPP in AAO nanotubes: (A) no peptide (B) 0.5% hIAPP20-29 (C) 0.75% hIAPP20-29
(D) 1% hIAPP20-29 (E) 1% hIAPP20-29 after incubation for 48 h (F) 1.25% hIAPP20-29 (G)
0.5% rIAPP20-29 (H) 1% rIAPP20-29.
For pure lipids, a single peak was observed in the 31P chemical spectrum at -13.0
ppm. This indicates an unperturbed lamellar phase lipid bilayer with a high degree of
alignment in the magnetic field. The low intensity broad signal is due to the unaligned lipids.
A small shift of the main peak, <0.5 ppm for hIAPP20-29 (Figure 8B and 8C) and ~3 ppm for
rIAPP20-29 (Fig. 8G and 8H), was observed. This could indicate that some of the peptides
bind to the lipid head group region, which could result in a change of the conformation of the
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lipid head group. This has been reported for other membrane surface binding peptides.45 The
31

P spectra suggest that at low (up to 0.75%, Fig. 8b) and high (>1.25%, Fig. 8F) mol % of

hIAPP20-29, lipid bilayers were in the lamellar phase with no observable disorder induced by
the peptide. An isotropic peak near -1ppm was observed within a narrow range of hIAPP20-29
mol % (~0.75% to 1.25%, Fig. 8C and 8D), suggesting peptide-induced membrane
fragmentation in the lipid bilayer. The slight deviation of this peak frequency from the
isotropic chemical shift and the line width (630-1090 Hz) could be due to restricted motion
and/or residual alignment of bilayer fragments in nanopores. An isotropic peak was still
observable after incubation for 48 hrs (Fig. 8E) but with some variations. The nonamyloidogenic hIAPP20-29 peptide did not show any isotropic shift at any concentration
(0.25% to 3 mol %, Fig. 8G and 8H). The inability of rIAPP20-29 at higher concentrations to
fragment the membrane indicates that peptide aggregation on membrane may play a crucial
role in this process.
To show the correlation between aggregation of hIAPP and membrane fragmentation,
Congo red was added to the hydration buffer of the sample. Congo red dye inhibits amyloid
formation by inhibiting the π-stacking interactions between peptides necessary for
amyloidogenesis.46 Congo red does not prevent binding of IAPP to the membrane as do some
inhibitors, like rifampicin.47
In Figure 9, Congo red suppresses the isotropic peak formation caused by 1% hIAPP
incompletely at 2 mol% (Fig. 9B) and completely at 5 mol% (Fig. 9C) of Congo Red. This
suggests that the isotropic peak is related to the potential of the peptide to form aggregates.
The isotropic peak indicative of membrane fragmentation is suppressed in the presence of
Congo red (Fig. 9B and 9C).
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Figure 9.
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P shift spectra of DMPC bilayers containing 1% hIAPP20-29 aligned in AAO

nanotubes with varying concentrations of Congo Red. (A) 0, (B) 2, and (C) 5 mol%.
As discussed previously and shown in Figures 8C and 8D, the higher concentrations
of hIAPP20-29 surprisingly also suppress membrane fragmentation. The standard detergentlike model for membrane fragmentation predicts membrane micellization after a threshold
peptide/lipid ratio is reached, and an increase in membrane fragmentation at higher
peptide/lipid ratios.48 Since membrane permeabilization in hIAPP and other amyloid peptides
is linked to the oligomeric state of the peptide, the lack of membrane fragmentation at higher
peptide/lipid ratios suggests a different oligomeric state at higher peptide/lipid ratios.
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The kinetics of fiber formation and the structures of amyloid fibers are dependent
upon the solution conditions of the fiber growth. Earlier studies have shown that monomeric
and fibrillar states of the protein are non-cytotoxic, but transient oligomeric intermediates
along the fibrilogenesis pathway show strong cytotoxicity. If these transient oligomeric
intermediates are responsible for the membrane fragmentation in Figures 8C and 8D, the
concentration of intermediate states responsible for membrane fragmentation may be
reduced, either through an alteration of the intial kinetic distribution of hIAPP20-29 oligomer
or a change in the kinetic pathway of fiber formation, to disfavor the formation of cytotoxic
oligomeric states at higher concentrations of hIAPP20-29.
A combination of 31P NMR and differential scanning calorimetry was used to
investigate the ability of hIAPP20-29 and rIAPP20-29 to induce membrane fragmentation. The
hIAPP20-29 and rIAPP20-29 induced changes on the thermotropic behavior of the lipid bilayers
as studied using DSC. The peak intensity of the representative curves is shown in Figures 1012. DSC results reflect the cooperativity of the gel to liquid crystal phase transition. When
the peptide binds at the surface it disrupts the ordered gel phase. This makes the gel phase
more similar to the liquid crystalline phase, lowering the intensity of the phase transition.
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Figure 10. Differential Scanning Calorimetry Scans of hIAPP20-29 (0.5%-4%).

Figure 11. Differential Scanning Calorimetry Scans rIAPP20-29 (0.5%-1%).

Figure 12. Differential Scanning Calorimetry Scans of rIAPP20-29 (1-4%).
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The molar heat capacity of the sample is slightly decreased in the presence of both the
human and rat forms of IAPP(20-29). The partially disordered system requires less energy for
the phase transition than an ordered system. This required energy is shown in terms of molar
heat capacity. This decrease in molar heat capacity values indicates that the peptide
penetrates partly into the hydrophobic core, disrupting lipid-lipid contact and inhibiting
cooperativity. The effect of 1% peptide is close to the maximal effect observed in both cases;
increasing concentration above 1% does not significantly increase the effect on the
membrane. This is in accordance with the NMR results. The rIAPP20-29 fragment shows a
membrane disrupting effect that increases with increasing concentration to 1% peptide, and
then decreasing again as the percent peptide rises above 1%. This may indicate aggregation
into domains at higher concentrations.
4.3 Peptide-Induced Membrane Disorder by Non-Amyloidogenic rIAPP20-29 in
DMPC/DHPC Bicelles
The 13C-1H NMR coupling analysis indicates that there is a decrease in dipolar coupling
values with an increase in the peptide concentration from 1 to 2%. The dipolar coupling
values at both concentrations of peptides were lower than that of pure 1, 2-dimyristoyl-snglycero-3-phosphocholine (DMPC) bicelles at all the carbon positions within the DMPC
bicelle. As shown in Figure 13, with increasing peptide concentrations, dipolar coupling
values varied significantly at carbon positions 2-11, which is composed of the hydrophobic
core. The variation in dipolar coupling at other carbon positions of DMPC is significantly
less, and, moreover, the dipolar coupling values at the γ, β, and  positions are nearly the
same. This indicates that rIAPP20-29 binds on the surface in the lipid headgroup region (γ- ).
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Figure 13.

13

C-1H dipolar coupling values of rIAPP20-29

A picture representation of a highly ordered membrane and disordered membrane are
shown in Figures 14A and 14B. A higher dipolar coupling value suggests an ordered
membrane, and a lower dipolar coupling value suggests disordered membrane.
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(A) Highly ordered membrane

(B) Disordered membrane

Figure 14. Dipolar coupling values with respect to membrane order. (A) Higher dipolar
coupling value suggests an ordered membrane and (B) lower dipolar coupling value suggests
disordered membrane.
It can be noted that most of the disruptive effect (disorder in the membrane as indicated
by a decrease in dipolar coupling) occurs at carbon positions 2-13 of the acyl chains and
some in the glycerol backbone (g3, g2 and g1), with little to no disruption in the head group.
This is indicative of a peptide that lies on the surface of the membrane and causes transient
deformations of the bilayer by intercalating into the hydrophobic core.
4.4 Mechanism for Membrane Disruption
The solid state NMR and the other techniques utilized have contributed greatly to the
understanding of the structures and mechanism of amyloid fibril formation and amyloid lipid
interaction. These open the possibility of not only understanding the in vivo fibrilzation
mechanism but also aiding in the design of the inhibitors of amyloid formation.
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A schematic of a possible pathway is illustrated in Figure 15. In this model, an
intermediate, pre-fibrillar form of hIAPP20-29 induces membrane fragmentation, but higher
concentrations lead to self-associating aggregates that are less membrane active.

Figure 15. A model for membrane fragmentation by hIAPP20-29. (A) represents lower
concentrations, where the peptide aggregates on the lipid bilayer surface to form an
intermediate state that is capable of extracting phospholipid molecules from the bilayer and
leading to peptide-lipid vesicles (B). (C) Represents an intermediate formed at higher
concentrations when the fiber formation follows an alternate pathway.50
A different mechanism was proposed in earlier research where the lipid molecules were
extracted directly from the membrane into the nascent amyloid fiber.30 If detached from the
membrane, the amyloid fibers would tumble rapidly in solution, and, therefore, the
phospholipid molecules trapped within the fibers would give rise to a motionally averaged
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isotropic 31P NMR signal. But the high percentage of lipid in the isotropic phase at a
relatively low peptide/lipid ratio suggests that this is not the mechanism primarly responsible
for membrane fragmentation under these experimental conditions, as it is not likely that the
amyloid fiber can incorporate a large excess of lipid molecules.
In agreement with the findings of the work presented here, membrane lesions have
been detected in a previous study by atomic force microscopy upon the addition of the
amyloidogneic human form of IAPP but not upon the addition of the non-amyloidogenic rat
form of IAPP.29 However, the experimental set up used in that study could not distinguish
between membrane lesions caused by a peptide induced bilayer expansion and membrane
lesions caused by micellization of the lipid bilayer.
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4.5 Amyloid Membrane Permeabilization as a Two-Step Process
Our results indicate that membrane permeabilization by IAPP20-29 has at least two
components. The PDLF experiments as well as DSC and dye leakage assays suggest that
both the human and the non-amyloidogenic rat variant of IAPP significantly disorder the
membrane, allowing transient pore formation. After a nucleation step, human IAPP (but not
non-amyloidogenic rat IAPP) may fragment the membrane by incorporating lipid molecules
into the amyloid fiber. This is shown in Figure 16.

Figure 16. Possible model of membrane activity for human and rat IAPP20-29.
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5. Summary
We have reported the direct detection of membrane fragmentation by the
amyloidogenic fragment of hIAPP20-29 and rIAPP20-29 using 31P solid-state NMR
spectroscopy. hIAPP20-29 causes membrane fragmentation over a narrow range of
concentrations, around 1% peptide. The fragmentation can be blocked by amyloidogenic
inhibitors. DSC studies suggest that membrane disordering is caused by both peptides
and the possible existence of peptide-free domains, which implies extensive aggregation
on the surface. The maximum effect is seen at 1% peptide for both human and rat
analogs. A time course dye leakage study suggests membrane fragmentation after a lag
phase for the human variant. The observations of membrane fragmentation in model
phospholipids membranes by hIAPP20-29 reported in this study suggest that hIAPP may
induce cytotoxicity by direct fragmentation of the cellular membrane. 13C-1H 2D PDLF
spectroscopy suggests that rIAPP20-29 causes transient deformations of the bilayer by
intercalating into the hydrophobic core. Data indicate that the fiber-forming process,
rather than the amyloid fiber itself, may be cytotoxic.
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6. Future Work
Insulin, which is co-secreted with hIAPP from the pancreatic β-cells acts as an
inhibitor of hIAPP’s oligomerization and eventual aggregation. HLVEALYLVC is
the fragment of insulin that makes contact with hIAPP.49 Though the decapeptide
covers the entire recognition region, the internal pentapeptide ALYLV is believed to
be most important since this region has sequence homology with the segment of IAPP
with which it makes contact.
A study is underway to find inhibitor of amylin in oligomerization based on
that fragment. The first step is to perform a truncation study to find the smallest
internal fragment that shows inhibitory properties. Unnatural amino acids can then be
incorporated at the Y position to alter conformation and increase the surface area for
pi stacking interactions that are believed to drive the aggregation process. The next
step is to determine the effect of these inhibitors on membranes in the presence of
hIAPP and elucidate their mechanism of action. This may lead to an eventual
treatment for the β-cell destruction associated with type II diabetes in our population.
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